Logo image of TOM2.AS

TOMTOM NV (TOM2.AS) Stock Fundamental Analysis

Europe - AMS:TOM2 - NL0013332471 - Common Stock

5.13 EUR
+0.1 (+2.09%)
Last: 11/7/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, TOM2 scores 3 out of 10 in our fundamental rating. TOM2 was compared to 103 industry peers in the Software industry. The financial health of TOM2 is average, but there are quite some concerns on its profitability. TOM2 has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

TOM2 had negative earnings in the past year.
TOM2 had a positive operating cash flow in the past year.
In the past 5 years TOM2 always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: TOM2 reported negative operating cash flow in multiple years.
TOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFTOM2.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

With a Return On Assets value of -2.47%, TOM2 is not doing good in the industry: 62.14% of the companies in the same industry are doing better.
TOM2 has a worse Return On Equity (-13.12%) than 68.93% of its industry peers.
TOM2 has a Return On Invested Capital of 2.14%. This is comparable to the rest of the industry: TOM2 outperforms 52.43% of its industry peers.
Industry RankSector Rank
ROA -2.47%
ROE -13.12%
ROIC 2.14%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
TOM2.AS Yearly ROA, ROE, ROICTOM2.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

TOM2 has a Operating Margin of 2.34%. This is comparable to the rest of the industry: TOM2 outperforms 49.51% of its industry peers.
TOM2 has a better Gross Margin (88.02%) than 81.55% of its industry peers.
TOM2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.34%
PM (TTM) N/A
GM 88.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
TOM2.AS Yearly Profit, Operating, Gross MarginsTOM2.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

4

2. Health

2.1 Basic Checks

TOM2 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, TOM2 has less shares outstanding
TOM2 has less shares outstanding than it did 5 years ago.
TOM2 has a worse debt/assets ratio than last year.
TOM2.AS Yearly Shares OutstandingTOM2.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOM2.AS Yearly Total Debt VS Total AssetsTOM2.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

TOM2 has a debt to FCF ratio of 4.47. This is a neutral value as TOM2 would need 4.47 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.47, TOM2 is in line with its industry, outperforming 53.40% of the companies in the same industry.
A Debt/Equity ratio of 0.23 indicates that TOM2 is not too dependend on debt financing.
TOM2's Debt to Equity ratio of 0.23 is in line compared to the rest of the industry. TOM2 outperforms 58.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 4.47
Altman-Z N/A
ROIC/WACC0.28
WACC7.65%
TOM2.AS Yearly LT Debt VS Equity VS FCFTOM2.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

TOM2 has a Current Ratio of 1.71. This is a normal value and indicates that TOM2 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.71, TOM2 is in the better half of the industry, outperforming 64.08% of the companies in the same industry.
A Quick Ratio of 1.67 indicates that TOM2 should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.67, TOM2 is in the better half of the industry, outperforming 66.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.67
TOM2.AS Yearly Current Assets VS Current LiabilitesTOM2.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

TOM2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.24%, which is quite impressive.
Looking at the last year, TOM2 shows a decrease in Revenue. The Revenue has decreased by -1.70% in the last year.
Measured over the past years, TOM2 shows a decrease in Revenue. The Revenue has been decreasing by -3.90% on average per year.
EPS 1Y (TTM)27.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%275%
Revenue 1Y (TTM)-1.7%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-2.7%

3.2 Future

Based on estimates for the next years, TOM2 will show a very strong growth in Earnings Per Share. The EPS will grow by 82.43% on average per year.
The Revenue is expected to grow by 7.40% on average over the next years.
EPS Next Y35.71%
EPS Next 2Y124.41%
EPS Next 3Y82.43%
EPS Next 5YN/A
Revenue Next Year-2.92%
Revenue Next 2Y0.22%
Revenue Next 3Y1.45%
Revenue Next 5Y7.4%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TOM2.AS Yearly Revenue VS EstimatesTOM2.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
TOM2.AS Yearly EPS VS EstimatesTOM2.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TOM2. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 17.75, TOM2 is valued on the expensive side.
73.79% of the companies in the same industry are more expensive than TOM2, based on the Price/Forward Earnings ratio.
TOM2's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 32.68.
Industry RankSector Rank
PE N/A
Fwd PE 17.75
TOM2.AS Price Earnings VS Forward Price EarningsTOM2.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

TOM2's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TOM2 is cheaper than 95.15% of the companies in the same industry.
TOM2's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 74.29
EV/EBITDA 5.29
TOM2.AS Per share dataTOM2.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TOM2's earnings are expected to grow with 82.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y124.41%
EPS Next 3Y82.43%

0

5. Dividend

5.1 Amount

No dividends for TOM2!.
Industry RankSector Rank
Dividend Yield N/A

TOMTOM NV

AMS:TOM2 (11/7/2025, 7:00:00 PM)

5.13

+0.1 (+2.09%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-14 2025-10-14
Earnings (Next)02-02 2026-02-02/amc
Inst Owners18.07%
Inst Owner ChangeN/A
Ins Owners51.4%
Ins Owner ChangeN/A
Market Cap641.25M
Revenue(TTM)565.73M
Net Income(TTM)-17.25M
Analysts45
Price Target6.09 (18.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.16%
PT rev (3m)11.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)58.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.75
P/S 1.13
P/FCF 74.29
P/OCF 18.02
P/B 4.88
P/tB N/A
EV/EBITDA 5.29
EPS(TTM)-0.15
EYN/A
EPS(NY)0.29
Fwd EY5.63%
FCF(TTM)0.07
FCFY1.35%
OCF(TTM)0.28
OCFY5.55%
SpS4.53
BVpS1.05
TBVpS-0.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.47%
ROE -13.12%
ROCE 2.86%
ROIC 2.14%
ROICexc 5.05%
ROICexgc N/A
OM 2.34%
PM (TTM) N/A
GM 88.02%
FCFM 1.53%
ROA(3y)-5.92%
ROA(5y)-10.94%
ROE(3y)-25.16%
ROE(5y)-35.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y2.76%
F-Score7
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 4.47
Debt/EBITDA 0.86
Cap/Depr 120.31%
Cap/Sales 4.76%
Interest Coverage 7.62
Cash Conversion 99.82%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.67
Altman-Z N/A
F-Score7
WACC7.65%
ROIC/WACC0.28
Cap/Depr(3y)20.27%
Cap/Depr(5y)16.21%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%275%
EPS Next Y35.71%
EPS Next 2Y124.41%
EPS Next 3Y82.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.7%
Revenue growth 3Y4.25%
Revenue growth 5Y-3.9%
Sales Q2Q%-2.7%
Revenue Next Year-2.92%
Revenue Next 2Y0.22%
Revenue Next 3Y1.45%
Revenue Next 5Y7.4%
EBIT growth 1Y153.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year197.14%
EBIT Next 3Y87.31%
EBIT Next 5YN/A
FCF growth 1Y260.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y643.88%
OCF growth 3Y-66.75%
OCF growth 5Y-57.16%

TOMTOM NV / TOM2.AS FAQ

What is the ChartMill fundamental rating of TOMTOM NV (TOM2.AS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to TOM2.AS.


What is the valuation status of TOMTOM NV (TOM2.AS) stock?

ChartMill assigns a valuation rating of 4 / 10 to TOMTOM NV (TOM2.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for TOMTOM NV?

TOMTOM NV (TOM2.AS) has a profitability rating of 2 / 10.


Can you provide the financial health for TOM2 stock?

The financial health rating of TOMTOM NV (TOM2.AS) is 4 / 10.


What is the earnings growth outlook for TOMTOM NV?

The Earnings per Share (EPS) of TOMTOM NV (TOM2.AS) is expected to grow by 35.71% in the next year.